Several studies have confirmed that the CD35 gene polymorphisms are closely related to a variety of malignant tumors, such as nasopharyngeal carcinoma, gallbladder cancer, bladder cancer, non-Hodgkin’s lymphoma, small cell lung cancer, stomach cancer, and ovarian cancer (24–26, 33). This evidence concerns the gene CR1 and ovarian cancer.